NEW YORK (GenomeWeb News) – Simulations Plus said today that it has signed a multi-year collaboration pact with Hoffmann La Roche, under which the pharmaceutical firm will provide funding and feedback in developing the firm’s GastroPlus software program for drug-drug interaction studies.
Lancaster, Calif.-based Simulations Plus said Roche would provide funding for the equivalent of one full-time scientist for two years.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.